PANews reported on October 8th that, according to data from Bloomberg analysts Eric Balchunas and James Seyffart, BlackRock's Bitcoin ETF is poised to surpass $100 billion in assets, driven by massive inflows and rising Bitcoin prices. Its revenue exceeds that of any of BlackRock's over 1,000 global funds. The fund, charging a 0.25% fee and generating over $240 million in annual revenue, has achieved remarkable results in less than two years. It reached the $100 billion milestone roughly five times faster than other ETFs, drawing capital from both retail and institutional investors. It is the "youngest by far" of the 20 largest ETFs, with the others taking years to reach this size. IBIT has become BlackRock's most profitable product, an impressive feat. Bloomberg analysts stated that they had optimistic expectations for demand and inflows, but the actual figures still exceeded even the most optimistic projections.PANews reported on October 8th that, according to data from Bloomberg analysts Eric Balchunas and James Seyffart, BlackRock's Bitcoin ETF is poised to surpass $100 billion in assets, driven by massive inflows and rising Bitcoin prices. Its revenue exceeds that of any of BlackRock's over 1,000 global funds. The fund, charging a 0.25% fee and generating over $240 million in annual revenue, has achieved remarkable results in less than two years. It reached the $100 billion milestone roughly five times faster than other ETFs, drawing capital from both retail and institutional investors. It is the "youngest by far" of the 20 largest ETFs, with the others taking years to reach this size. IBIT has become BlackRock's most profitable product, an impressive feat. Bloomberg analysts stated that they had optimistic expectations for demand and inflows, but the actual figures still exceeded even the most optimistic projections.

BlackRock's Bitcoin ETF has assets approaching $100 billion, making it BlackRock's most profitable product.

2025/10/08 08:51

PANews reported on October 8th that, according to data from Bloomberg analysts Eric Balchunas and James Seyffart, BlackRock's Bitcoin ETF is poised to surpass $100 billion in assets, driven by massive inflows and rising Bitcoin prices. Its revenue exceeds that of any of BlackRock's over 1,000 global funds. The fund, charging a 0.25% fee and generating over $240 million in annual revenue, has achieved remarkable results in less than two years. It reached the $100 billion milestone roughly five times faster than other ETFs, drawing capital from both retail and institutional investors. It is the "youngest by far" of the 20 largest ETFs, with the others taking years to reach this size. IBIT has become BlackRock's most profitable product, an impressive feat. Bloomberg analysts stated that they had optimistic expectations for demand and inflows, but the actual figures still exceeded even the most optimistic projections.

Aviso legal: Los artículos republicados en este sitio provienen de plataformas públicas y se ofrecen únicamente con fines informativos. No reflejan necesariamente la opinión de MEXC. Todos los derechos pertenecen a los autores originales. Si consideras que algún contenido infringe derechos de terceros, comunícate con service@support.mexc.com para solicitar su eliminación. MEXC no garantiza la exactitud, la integridad ni la actualidad del contenido y no se responsabiliza por acciones tomadas en función de la información proporcionada. El contenido no constituye asesoría financiera, legal ni profesional, ni debe interpretarse como recomendación o respaldo por parte de MEXC.
Compartir perspectivas

También te puede interesar

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Compartir
BitcoinEthereumNews2025/09/18 03:11
Compartir